When this is not reached, it leads to various pathophysiological processes that promote inflammation, the aggregation of alpha-synuclein in dopaminergic neurons [8], and, ultimately, cell death (degeneration) and the development of GBA1-PD [13]. Here, GBA1 is linked to Parkinson disease.